Immunoliposomal Delivery of 213Bi for -Emitter Targeting of Metastatic Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-4548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities

Nanomaterials
Materials ScienceChemical Engineering
2018English

Targeting Underglycosylated MUC1 for the Selective Capture of Highly Metastatic Breast Cancer Cells Under Flow

Cellular and Molecular Bioengineering
BiochemistryModelingGeneticsMolecular BiologySimulation
2013English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Precision Medicine for Metastatic Breast Cancer

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2015English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

Mammosphere Culture of Metastatic Breast Cancer Cells Enriches for Tumorigenic Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2008English

Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells

2002English

Delivery Rate Affects Uptake of a Fluorescent Glucose Analog in Murine Metastatic Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells

2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy